Amgen (AMGN)

Market Cap

$241.81B

Current · Retrieved: · USD

AMGN logo

AMGN Market Cap

Current$241.81B
AMGN Market Cap ($185.84M → $241.81B · CAGR +18.0%)
High-resolution chart · PNG

AMGN market cap history

Daily history. Dates identify market observations.

Amgen Market Cap — Daily history
DateMarket Cap
188,388,626,720
185,761,155,200
177,760,017,853
177,494,891,920
177,335,243,290
177,851,709,040
175,326,957,600
175,997,341,280
177,630,049,920
178,468,029,520
184,701,516,480
178,500,467,440
173,391,495,040
177,132,668,480
176,954,259,920
177,700,332,080
178,208,526,160
179,992,611,760
179,160,038,480
179,160,038,480
176,992,104,160
175,391,833,440
175,391,833,440
175,391,833,440
176,251,438,320
176,646,099,680
175,872,995,920
171,780,411,680
171,585,784,160
171,585,784,160
171,585,784,160
170,504,520,160
169,677,353,200
173,667,217,360
178,349,090,480
183,901,381,120
183,901,381,120
183,901,381,120
186,745,105,440
182,928,243,520
182,457,893,680
186,766,730,720
186,285,568,240
186,285,568,240
186,285,568,240
184,414,981,520
184,414,981,520
180,733,277,600
182,484,925,280
181,690,196,240
181,690,196,240
181,690,196,240
185,112,396,800
185,972,001,680
184,739,360,720
182,052,419,680
181,652,352,000
181,652,352,000
181,652,352,000
181,803,728,960
182,976,900,400
174,980,953,120
173,110,366,400
170,618,052,880
170,618,052,880
170,618,052,880
172,926,551,520
160,405,514,400
160,189,261,600
161,340,807,760
157,864,544,000
157,864,544,000
157,864,544,000
157,740,198,640
157,913,200,880
157,410,413,120
157,734,792,320
158,345,706,480
158,345,706,480
158,345,706,480
160,016,259,360
162,805,920,480
163,989,904,560
161,546,247,920
159,924,351,920
159,924,351,920
159,924,351,920
160,740,706,240
158,864,713,200
158,083,499,960
156,853,562,160
159,718,911,760
159,718,911,760
159,718,911,760
159,280,999,840
159,778,381,280
159,010,683,840
161,048,866,480
160,783,956,800
160,783,956,800
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.